OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY
Frank Behrens, P. C. Taylor, Dieter Wetzel, N. C. Brun, J. Brandt-Juergens, E. Drescher, E. Dokoupilova, A. Rowińska-Osuch, Nadia Abdel-Kader Martin, K. de Vlam
Topics & Concepts
MedicinePsoriatic arthritisDactylitisTolerabilityPlaceboInternal medicineClinical endpointEnthesitisPsoriasisPlacebo-controlled studyArthritisRheumatoid arthritisAdverse effectRandomized controlled trialSurgeryDermatologyDouble blindPathologyAlternative medicinePsoriasis: Treatment and PathogenesisInflammatory mediators and NSAID effectsCytokine Signaling Pathways and Interactions